Ownership history in Ghost Tree Capital, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which Ghost Tree Capital, LLC reported a position in INTRA CELLULAR THERAPIES INC (ITCI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | REDUCED | 10,000 | -40,000 | -80.0% | 0.21% | $685K | — |
| 2024 Q1 | REDUCED | 50,000 | -10,000 | -16.7% | 0.96% | $3.5M | — |
| 2022 Q3 | REDUCED | 60,000 | -19,400 | -24.4% | 0.78% | $2.8M | — |
| 2018 Q4 | REDUCED | 79,400 | -120,600 | -60.3% | 0.56% | $1.6M | — |
| 2017 Q2 | REDUCED | 200,000 | -300,000 | -60.0% | 0.52% | $2.5M | — |
| 2017 Q2 | ADDED | 500,000 | +350,000 | +233.3% | 1.29% | $6.2M | — |
| 2017 Q1 | ADDED | 150,000 | +30,000 | +25.0% | 0.45% | $2.4M | — |
| 2016 Q2 | INITIATED | 120,000 | — | — | 1.35% | $4.7M | — |